Back
Day Range
$114.62
$117.33
52-Week Range
$114.36
$172.23
Volume
2,631,985
50D / 200D Avg
$124.41
/
$138.35
Prev Close
$115.67
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (626 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | 19.0 | 0.4 |
| P/B | 15.2 | 2.9 |
| ROE % | 66.0 | 3.8 |
| Net Margin % | 28.2 | 3.9 |
| Rev Growth 5Y % | 5.0 | 10.0 |
| D/E | 2.9 | 0.2 |
Key Takeaways
Revenue grew 5.04% annually over 5 years — modest growth
ROE of 65.99% indicates high profitability
Net margin of 28.23% shows strong profitability
Debt/Equity of 2.85 — high leverage
Generating 2.28B in free cash flow
Cash machine — converts 85.41% of earnings into free cash flow
Growth
Revenue Growth (5Y)
5.04%
Revenue (1Y)2.28%
Earnings (1Y)7.52%
FCF Growth (3Y)18.68%
Quality
Return on Equity
65.99%
ROIC21.04%
Net Margin28.23%
Op. Margin38.00%
Safety
Debt / Equity
2.85
Current Ratio3.03
Interest Coverage14.80
Valuation
P/E Ratio
19.00
P/B Ratio15.24
EV/EBITDA16.11
Dividend Yield0.02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 2.28% | Revenue Growth (3Y) | 5.26% |
| Earnings Growth (1Y) | 7.52% | Earnings Growth (3Y) | 6.79% |
| Revenue Growth (5Y) | 5.04% | Earnings Growth (5Y) | 7.03% |
| Profitability | |||
| Revenue (TTM) | 9.47B | Net Income (TTM) | 2.67B |
| ROE | 65.99% | ROA | 17.28% |
| Gross Margin | 70.49% | Operating Margin | 38.00% |
| Net Margin | 28.23% | Free Cash Flow (TTM) | 2.28B |
| ROIC | 21.04% | FCF Growth (3Y) | 18.68% |
| Safety | |||
| Debt / Equity | 2.85 | Current Ratio | 3.03 |
| Interest Coverage | 14.80 | Dividend Yield | 0.02% |
| Valuation | |||
| P/E Ratio | 19.00 | P/B Ratio | 15.24 |
| P/S Ratio | 5.36 | PEG Ratio | 2.04 |
| EV/EBITDA | 16.11 | Dividend Yield | 0.02% |
| Market Cap | 50.78B | Enterprise Value | 57.96B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 9.47B | 9.26B | 8.54B | 8.08B | 7.78B |
| Net Income | 2.67B | 2.49B | 2.34B | 2.11B | 2.04B |
| EPS (Diluted) | 6.02 | 5.47 | 5.07 | 4.49 | 4.27 |
| Gross Profit | 6.67B | 6.40B | 5.83B | 5.48B | 5.31B |
| Operating Income | 3.60B | 3.39B | 3.07B | 2.93B | 2.80B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 15.47B | 14.24B | 14.29B | 14.93B | 13.90B |
| Total Liabilities | 12.14B | 9.47B | 9.30B | 10.52B | 9.36B |
| Shareholders' Equity | 3.33B | 4.77B | 5.00B | 4.41B | 4.54B |
| Total Debt | 9.49B | 6.74B | 6.76B | 8.09B | 6.74B |
| Cash & Equivalents | 2.31B | 1.99B | 2.04B | 3.58B | 3.48B |
| Current Assets | 6.77B | 5.99B | 6.34B | 7.51B | 6.93B |
| Current Liabilities | 2.24B | 3.41B | 1.89B | 3.17B | 1.80B |